Fri, March 4, 2022
Thu, March 3, 2022
Wed, March 2, 2022
Tue, March 1, 2022
Mon, February 28, 2022
Sun, February 27, 2022
Fri, February 25, 2022

Eric Joseph Maintained (AVIR) at Hold with Decreased Target to $8 on, Mar 2nd, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -with-decreased-target-to-8-on-mar-2nd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Eric Joseph of JP Morgan, Maintained "Atea Pharmaceuticals, Inc." (AVIR) at Hold with Decreased Target from $10 to $8 on, Mar 2nd, 2022.

Eric has made no other calls on AVIR in the last 4 months.



There are 2 other peers that have a rating on AVIR. Out of the 2 peers that are also analyzing AVIR, 1 agrees with Eric's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Roanna Ruiz of "SVB Leerink" Maintained at Hold with Decreased Target to $9 on, Tuesday, March 1st, 2022


This is the rating of the analyst that currently disagrees with Eric


  • Matthew Harrison of "Morgan Stanley" Downgraded from Hold to Sell and Decreased Target to $7 on, Thursday, January 6th, 2022

Publication Contributing Sources